Thiamine Supplementation Fatigue Meta-analysis: What the Evidence Says
Thiamine Supplementation Fatigue Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first p
Quick Answer
Thiamine Supplementation Fatigue Meta analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public health sources, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 1 narrative review, 1 preclinical study.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Thiamine Supplementation Fatigue Meta-analysis: What the Evidence Says
Quick Answer
Thiamine Supplementation Fatigue Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 narrative review, 1 preclinical study.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Thiamine Use in Hospitalized Patients: A Clinical Review | narrative review | 3 | 2026-02-11 | 10.1155/jnme/7143046 |
| PHARMACOLOGICAL TREATMENTS FOR FATIGUE IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN INTEGRATIVE REVIEW | preclinical study | 4 | 2026-01-09 | 10.1590/S0004-2803.24612025-081 |
What The Sources Report
- However, in the absence of sufficient oxygen, pyruvate is shunted to the lactic acid cycle where it is reduced to lactate. [Rosewarne Rowan E. (2026); evidence level 3]
- This pathway is essential to produce reduced nicotinamide adenine dinucleotide-phosphate (NADPH), which is used for many functions within the body like synthesis of fatty acids, maintenance of myelin sheaths, nerve membrane function, and transmission. [Rosewarne Rowan E. (2026); evidence level 3]
- The etiology of fatigue in IBD is multifactorial and may be associated with inflammation, anemia, nutrient deficiencies, medications, and microbiota. [MORAIS Tayane (2026); evidence level 4]
- Fatigue in patients with IBD is associated with decreased physical functioning, mood disturbances, and low productivity, presenting symptoms of physical and mental exhaustion. [MORAIS Tayane (2026); evidence level 4]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
For thiamine supplementation fatigue meta-analysis, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Rosewarne Rowan E. (2026). Thiamine Use in Hospitalized Patients: A Clinical Review. DOI: 10.1155/jnme/7143046. PMCID: PMC12893098. PMID: 41684754. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12893098/
- MORAIS Tayane (2026). PHARMACOLOGICAL TREATMENTS FOR FATIGUE IN INFLAMMATORY BOWEL DISEASE PATIENTS: AN INTEGRATIVE REVIEW. DOI: 10.1590/S0004-2803.24612025-081. PMCID: PMC12788763. PMID: 41538673. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12788763/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed July 27, 2026 by Migaku Evidence Review
